Difference between revisions of "Risedronate (Actonel)"
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
Line 16: | Line 16: | ||
<references/> | <references/> | ||
− | [[Category: | + | [[Category:Drugs]] |
[[Category:Bisphosphonates]] | [[Category:Bisphosphonates]] |
Revision as of 23:01, 13 June 2018
Also known as Actonel Einmal Woechentlich, Actonel O.A.W., Actonel one a week, Actonel Wekelijks, Actonel with Calcium, Atelvia, Benet, Ductonar, Gemfos, Maxidronato, NE 58095, Optinate, Optinate Septimum, Orafix, Osteonate, Osteorise, Ridron, Rised, Risedon, risedronic acid, risedronate sodium, Risendal, Risofos, Sedron, Seralis.
General information
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2][3]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Patient counseling information can be found on page 33-39 of the Risedronate (Actonel) package insert[1]
- Risedronate (Actonel) patient drug information (UpToDate)[4]